George Carnell

1.5k total citations
35 papers, 708 citations indexed

About

George Carnell is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, George Carnell has authored 35 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 18 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in George Carnell's work include SARS-CoV-2 and COVID-19 Research (17 papers), Influenza Virus Research Studies (17 papers) and Respiratory viral infections research (13 papers). George Carnell is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), Influenza Virus Research Studies (17 papers) and Respiratory viral infections research (13 papers). George Carnell collaborates with scholars based in United Kingdom, Germany and United States. George Carnell's co-authors include Nigel Temperton, Jonathan L. Heeney, Nicholas Johnson, Karen L. Mansfield, Anthony R. Fooks, Claire L. Jeffries, Francesca Ferrara, Craig Thompson, Keith Grehan and Leo L. M. Poon and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

George Carnell

32 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Carnell United Kingdom 13 434 287 147 133 113 35 708
Rashid Manzoor Japan 16 403 0.9× 479 1.7× 137 0.9× 125 0.9× 44 0.4× 34 789
Jing-Hui Tian United States 11 448 1.0× 171 0.6× 166 1.1× 176 1.3× 122 1.1× 14 687
Thomas F. Rogers United States 8 422 1.0× 136 0.5× 155 1.1× 160 1.2× 77 0.7× 21 665
Laura Perez Vidakovics Sweden 15 337 0.8× 266 0.9× 293 2.0× 156 1.2× 64 0.6× 22 906
Marintha Heil United States 14 539 1.2× 269 0.9× 140 1.0× 241 1.8× 125 1.1× 21 939
Sumathy Velumani Singapore 12 227 0.5× 308 1.1× 130 0.9× 110 0.8× 132 1.2× 14 542
Joseph P. Nkolola United States 19 388 0.9× 169 0.6× 268 1.8× 337 2.5× 45 0.4× 29 899
Séverine Mercier‐Delarue France 17 456 1.1× 335 1.2× 141 1.0× 70 0.5× 81 0.7× 48 905
Sara B. Griesemer United States 13 307 0.7× 794 2.8× 298 2.0× 88 0.7× 71 0.6× 19 1.0k
Adam J. Foord Australia 14 566 1.3× 547 1.9× 110 0.7× 52 0.4× 108 1.0× 18 840

Countries citing papers authored by George Carnell

Since Specialization
Citations

This map shows the geographic impact of George Carnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Carnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Carnell more than expected).

Fields of papers citing papers by George Carnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Carnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Carnell. The network helps show where George Carnell may publish in the future.

Co-authorship network of co-authors of George Carnell

This figure shows the co-authorship network connecting the top 25 collaborators of George Carnell. A scholar is included among the top collaborators of George Carnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Carnell. George Carnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carnell, George, Phil Palmer, Lorraine A. O’Reilly, et al.. (2025). Computationally designed haemagglutinin with nanocage plug-and-display elicits pan-H5 influenza vaccine responses. Emerging Microbes & Infections. 14(1). 2511132–2511132.
2.
Moss, Ronald B., Sheeba J. Sujit, Paul Tonks, et al.. (2025). Development of Pan-H5 Vaccines Against Avian Influenza Developed Using Computational Biology to Mitigate Future Pandemics. Journal of Allergy and Clinical Immunology. 155(2). AB448–AB448.
3.
Ahmed, Mohamed I. M., Sebastian Einhauser, Tabea M. Eser, et al.. (2024). Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection. iScience. 27(6). 110138–110138. 2 indexed citations
4.
Nadesalingam, Angalee, Andrew Chan, Peter Smith, et al.. (2023). Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies. SHILAP Revista de lepidopterología. 2(2). 100091–100091. 3 indexed citations
5.
Carnell, George, et al.. (2023). Immune imprinting and next-generation coronavirus vaccines. Nature Microbiology. 8(11). 1971–1985. 29 indexed citations
6.
Stewart, Hazel, Roberta Palmulli, K. Johansen, et al.. (2023). Tetherin antagonism by SARS‐CoV ‐2 ORF3a and spike protein enhances virus release. EMBO Reports. 24(12). e57224–e57224. 11 indexed citations
7.
Su, Jinpeng, Romina Bester, George Carnell, et al.. (2023). Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice. European Journal of Pharmaceutics and Biopharmaceutics. 192. 41–55. 4 indexed citations
8.
Nadesalingam, Angalee, Diego Cantoni, Minna Paloniemi, et al.. (2022). Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies. The Lancet Microbe. 4(2). e58–e59. 9 indexed citations
9.
Cantoni, Diego, Martin Mayora Neto, Angalee Nadesalingam, et al.. (2022). Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds. Frontiers in Immunology. 13. 773982–773982. 12 indexed citations
10.
Palmer, Phil, et al.. (2022). AutoPlate: Rapid Dose-Response Curve Analysis for Biological Assays. Frontiers in Immunology. 12. 681636–681636. 3 indexed citations
11.
Carnell, George, Kathrin Held, Guidenn Sulbarán, et al.. (2021). Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses. Vaccines. 9(7). 750–750. 9 indexed citations
12.
Nadesalingam, Angalee, Diego Cantoni, David A. Wells, et al.. (2021). Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK. The Lancet Microbe. 2(9). e416–e418. 10 indexed citations
13.
Ferrara, Francesca, Simon D. Scott, Sasan Fereidouni, et al.. (2021). Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies. Frontiers in Immunology. 12. 661379–661379. 9 indexed citations
14.
Gaiotto, Tiziano, Paul Risley, George Carnell, et al.. (2021). Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display. Scientific Reports. 11(1). 3126–3126. 23 indexed citations
15.
Baxendale, Helen, David A. Wells, George Carnell, et al.. (2021). Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19. SHILAP Revista de lepidopterología. 7(3). 199–210. 3 indexed citations
16.
Genova, Cecilia Di, Diego Cantoni, Martin Mayora Neto, et al.. (2020). Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypes. Figshare. 5 indexed citations
17.
Giotis, Efstathios S., George Carnell, Erik F. Young, et al.. (2019). Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor. Nature Microbiology. 4(12). 2035–2038. 32 indexed citations
18.
Dong, Wei, Tjarko Meijerhof, Kate Guilfoyle, et al.. (2018). Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines. Frontiers in Immunology. 9. 2312–2312. 27 indexed citations
19.
Thompson, Craig, José Lourenço, Adam A. Walters, et al.. (2018). A naturally protective epitope of limited variability as an influenza vaccine target. Nature Communications. 9(1). 3859–3859. 29 indexed citations
20.
Valkenburg, Sophie A., Vamsee Mallajosyula, Olive T. W. Li, et al.. (2016). Stalking influenza by vaccination with pre-fusion headless HA mini-stem. Scientific Reports. 6(1). 22666–22666. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026